You have 9 free searches left this month | for more free features.

Telmisartan

Showing 26 - 50 of 347

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5

Recruiting
  • Hypertension
  • Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
  • +7 more
  • Phoenix, Arizona
  • +84 more
Aug 19, 2022

Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide

Recruiting
  • Covid19
  • +3 more
  • Nitazoxanide and Ciclésonide
  • +3 more
  • Bobo-Dioulasso, Burkina Faso
  • +1 more
Jan 30, 2023

Primary Hypercholesterolemia, Hypertension Trial in Daegu (Experimental : Ezetimibe / Rosuvastatin + Telmisartan, Active

Recruiting
  • Primary Hypercholesterolemia
  • Hypertension
  • Experimental : Ezetimibe / Rosuvastatin + Telmisartan
  • +2 more
  • Daegu, Korea, Republic of
    Daegu Catholic Univ Medical Center
Dec 2, 2020

Replication of ONTARGET Antihypertensive Trial in Healthcare

Completed
  • Hypertension
  • Boston, Massachusetts
    Brigham And Women's Hospital
Jun 21, 2021

Replication of TRANSCEND Antihypertensive Trial in Healthcare

Completed
  • Hypertension
  • Loop diuretics, thiazides, dihydropyridines
  • Telmisartan
  • Boston, Massachusetts
    Brigham And Women's Hospital
Jun 21, 2021

Corona Virus Infection, Sars-CoV2 Trial in France (Vitamins, Telmisartan, Ciclesonide)

Completed
  • Corona Virus Infection
  • Sars-CoV2
  • Vitamins
  • +3 more
  • Bordeaux, France
  • +6 more
Feb 3, 2022

COVID-19, Respiratory Insufficiency, Telmisartan Trial in Zumpango (Telmisartan)

Unknown status
  • COVID-19
  • +3 more
  • Telmisartan
  • Zumpango, Estado De Mexico, Mexico
    Hospital Regional de Alta Especialidad de Zumpango
Aug 11, 2020

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Completed
  • Hypertension
  • COVID
  • Salt Lake City, Utah
    University of Utah
Apr 26, 2021

Abdominal Aortic Aneurysm Trial in Palo Alto (Telmisartan, Placebo)

Completed
  • Abdominal Aortic Aneurysm
  • Telmisartan
  • Placebo
  • Palo Alto, California
    VA Palo Alto Health Care System
May 21, 2020

Stroke, Cerebral Small Vessel Diseases, Intracerebral Hemorrhage Trial in Liverpool, Birtinya, Melbourne (telmisartan 20 mg +

Terminated
  • Stroke
  • +4 more
  • telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg
  • Placebo oral capsule
  • Liverpool, New South Wales, Australia
  • +2 more
May 24, 2021

Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)

Completed
  • Coronavirus Disease 2019
  • COVID-19
  • Angiotensin Receptor Blockers
  • Placebo
  • Camperdown, New South Wales, Australia
  • +21 more
Mar 2, 2022

Hypertension Trial in Korea, Republic of (Telminuvo®Tab. 40/2.5mg, Telmitrend®Tab. 80mg)

Completed
  • Hypertension
  • Telminuvo®Tab. 40/2.5mg
  • Telmitrend®Tab. 80mg
  • Gyeonggi-do, Ansan-si, Korea, Republic of
  • +10 more
Jan 29, 2020

Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular Trial in Australia, Netherlands (telmisartan 20mg + amlodipine

Terminated
  • Cognitive Decline
  • +5 more
  • telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg
  • Placebo oral capsule
  • Liverpool, New South Wales, Australia
  • +3 more
Mar 29, 2021

Hypertension, Insulin Resistance, Dyslipidemia Trial in Stanford (Telmisartan)

Terminated
  • Hypertension
  • +2 more
  • Telmisartan
  • Stanford, California
    Stanford Medical Center
Mar 16, 2020

Acute HIV Infection, HIV Trial in Bangkok (Telmisartan)

Completed
  • Acute HIV Infection
  • HIV Infections
  • Telmisartan
  • Bangkok, Thailand
  • +1 more
Mar 4, 2020

Chronic Kidney Disease, Proteinuria Trial in Korea, Republic of (Telmisartan/Rosuvastatin 40/10mg, Telmisartan 40mg)

Unknown status
  • Chronic Kidney Disease
  • Proteinuria
  • Telmisartan/Rosuvastatin 40/10mg
  • Telmisartan 40mg
  • Wŏnju, Gangwon-do, Korea, Republic of
  • +15 more
Dec 11, 2020

COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Abidjan (Lopinavir/Ritonavir 200

Recruiting
  • COVID-19
  • +2 more
  • Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet
  • +2 more
  • Abidjan, Côte D'Ivoire
  • +1 more
Feb 3, 2021

Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)

Suspended
  • Hypertension
  • COVID-19
  • Thiazide or Thiazide-like diuretics
  • +3 more
  • Galway, Ireland
    University Hospital Galway
Jun 26, 2020

Micatrio® Combination Tablets Treatment in Hypertension

Completed
  • Hypertension
  • T80/A5/H12.5 FDC
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd
May 7, 2020

Acute HIV Infection, HIV CNS Involvement Trial in Bangkok (TDF/3TC/EFV + Telmisartan, TDF/3TC/EFV only)

Completed
  • Acute HIV Infection
  • HIV CNS Involvement
  • TDF/3TC/EFV + Telmisartan
  • TDF/3TC/EFV only
  • Bangkok, Thailand
    SEARCH Thailand
Sep 17, 2019

Hypertension With Dyslipidemia Trial in Jeonju (JLP-1401, Telmisartan/Amlodipine, Rosuvastatin)

Completed
  • Hypertension With Dyslipidemia
  • JLP-1401
  • Telmisartan/Amlodipine, Rosuvastatin
  • Jeonju, Korea, Republic of
    Chonbuk National University Hospital
Aug 27, 2019

Hypertension Trial in Xi'an (telmisartan, amlodipine)

Unknown status
  • Hypertension
  • Xi'an, Shanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 6, 2019

Telmisartan in Real Clinical Conditions With Goal to Control

Completed
  • Hypertension
  • telmisartan
  • Boehringer Ingelheim Investigational Site, Belgium
  • +11 more
Nov 4, 2019

Hypertension Trial in Cheongju-si (Telmione plus 80/12.5mg, Micardis plus 80/12.5mg)

Completed
  • Hypertension
  • Telmione plus 80/12.5mg
  • Micardis plus 80/12.5mg
  • Cheongju-si, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Feb 14, 2022

Hypertension Trial in Seoul (Nebivolol)

Active, not recruiting
  • Hypertension
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Apr 6, 2022